Cytosorbents Corporation
UEI: V2Y7G7L3ADL3
• CAGE: 7T6X7
• DBA: CYTOSORBENTS
Overview
Awardee Type
Parent
(1 child)
Company Description
CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based, critical care company specializing in blood purification to treat life-threatening conditions in the intensive care unit and cardiac surgery.
Name
Cytosorbents Corporation
Website
Headquarters
Monmouth Junction, NJ
United States
United States
Most Recent Award
May 12, 2023
Calculating
Federal contract and grant recipient
CYTOSORBENTS CORPORATION
dba CYTOSORBENTS
(UEI V2Y7G7L3ADL3, CAGE 7T6X7)
is headquartered in Monmouth Junction NJ.
Its primary registered NAICS is 339112 Surgical and Medical Instrument Manufacturing.
The corporation
was founded in November 2003 and
federally registered in
November 2016.
Federal Award Analysis
Cytosorbents Corporation federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
CYTOSORBENTS CORPORATION
DBA
CYTOSORBENTS
UEI
V2Y7G7L3ADL3
CAGE Code
7T6X7
Primary NAICS
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Nov. 19, 2003
Initial Registration
Nov. 15, 2016
Last Registration
Oct. 27, 2022
Registration Activation
Sept. 29, 2021
Registration Expiration
Oct. 27, 2022
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No